*. Les-symboles, *. *. , and *. *. , * correspondent respectivement à un seuil de significativité p<0, pp.0-01

R. Li and J. Emsley, The organizing principle of the platelet glycoprotein Ib-IX-V complex, Journal of Thrombosis and Haemostasis, vol.106, issue.4, pp.605-619, 2013.
DOI : 10.1182/blood-2005-01-0440

M. Hoffman and D. Monroe, Coagulation 2006: A Modern View of Hemostasis, Hematology/Oncology Clinics of North America, vol.21, issue.1, pp.1-11, 2007.
DOI : 10.1016/j.hoc.2006.11.004

E. De-raucourt, F. Bauduer, B. Pan-petesh, and J. Goudemand, Déficit en facteur XI, Hemotologie, vol.16, pp.284-92, 2010.

T. Nakagaki, D. Foster, K. Berkner, and W. Kisiel, Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII, Biochemistry, vol.30, issue.45, pp.10819-10843, 1991.
DOI : 10.1021/bi00109a001

K. Siebenlist, M. Mosesson, I. Hernandez, L. Bush, D. Cera et al., Studies on the basis for the properties of fibrin produced from fibrinogen-containing ?' chains, Blood, vol.106, issue.8, pp.2730-2736, 2005.
DOI : 10.1182/blood-2005-01-0240

D. Monroe and N. Key, The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking, Journal of Thrombosis and Haemostasis, vol.4, issue.Suppl., pp.1097-105, 2007.
DOI : 10.1161/01.ATV.20.3.874

T. Syrovets, O. Lunov, and T. Simmet, Plasmin as a proinflammatory cell activator, Journal of Leukocyte Biology, vol.92, issue.3, pp.509-528, 2012.
DOI : 10.1189/jlb.0212056

B. Bouma and L. Mosnier, Thrombin activatable fibrinolysis inhibitor (TAFI)?How does thrombin regulate fibrinolysis?, Annals of Medicine, vol.41, issue.255, pp.378-88, 2006.
DOI : 10.1053/j.seminhematol.2003.11.004

C. Mahan, S. Barco, and A. Spyropoulos, Cost-of-illness model for venous thromboembolism, Thrombosis Research, vol.145, p.2016
DOI : 10.1016/j.thromres.2016.06.022

J. Hippisley-cox and C. Coupland, Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study, BMJ, vol.343, issue.aug16 1, pp.46-56, 2011.
DOI : 10.1136/bmj.d4656

J. Dalen, Pulmonary Embolism: What have We Learned Since Virchow?, Chest, vol.122, issue.4, pp.1440-56, 2002.
DOI : 10.1378/chest.122.4.1440

I. Naess, S. Christiansen, P. Romundstad, S. Cannegieter, F. Rosendaal et al., Incidence and mortality of venous thrombosis: a population-based study, Journal of Thrombosis and Haemostasis, vol.34, issue.4, pp.692-701, 2007.
DOI : 10.1056/NEJM200012213432504

M. Rogers, D. Levine, N. Blumberg, S. Flanders, V. Chopra et al., Triggers of Hospitalization for Venous Thromboembolism, Circulation, vol.125, issue.17, pp.2092-2101, 2012.
DOI : 10.1161/CIRCULATIONAHA.111.084467

A. Khorana and G. Connolly, Assessing Risk of Venous Thromboembolism in the Patient With Cancer, Journal of Clinical Oncology, vol.27, issue.29, pp.4839-4886, 2009.
DOI : 10.1200/JCO.2009.22.3271

E. Battinelli, A. Marshall, and J. Connors, The Role of Thrombophilia in Pregnancy, Thrombosis, vol.100, issue.3, p.516420, 2013.
DOI : 10.1016/S0002-9378(96)70610-5

M. Cushman, Epidemiology and Risk Factors for Venous Thrombosis, Seminars in Hematology, vol.44, issue.2, pp.62-71, 2007.
DOI : 10.1053/j.seminhematol.2007.02.004

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020806

O. Egerberg, Inherited antithrombin deficiency causig thrombophilia. Thromb diat hemorra, pp.516-546, 1965.

P. Cooper, F. Coath, M. Daly, and M. Makris, The phenotypic and genetic assessment of antithrombin deficiency, International Journal of Laboratory Hematology, vol.12, issue.3, pp.227-264, 2011.
DOI : 10.1097/00001721-200106000-00002

S. Kristensen, M. Käehne, and N. Petersen, Hemizygous antithrombin-deficiency (Budapest III) in a newborn presenting with a thrombosis at birth, British Journal of Haematology, vol.76, issue.3, pp.397-405, 2007.
DOI : 10.1016/0014-5793(92)80854-A

J. Griffin, B. Evatte, T. Zimmerman, A. Kleiss, and C. Wideman, Deficiency of protein C in congenital thrombotic disease., Journal of Clinical Investigation, vol.68, issue.5, pp.1370-1373, 1981.
DOI : 10.1172/JCI110385

P. Medina, S. Navarro, A. Estellés, and F. Espana, Polymorphisms in the endothelial protein C receptor gene and thrombophilia, Thrombosis and Haemostasis, vol.98, pp.564-573, 2007.
DOI : 10.1160/TH07-01-0071

P. Comp, R. Nixon, M. Cooper, and C. Esmon, Familial protein S deficiency is associated with recurrent thrombosis., Journal of Clinical Investigation, vol.74, issue.6, pp.2082-2090, 1984.
DOI : 10.1172/JCI111632

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC425398

R. Bertina, B. Koeleman, T. Koster, F. Rosendaal, R. Dirven et al., Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature, vol.369, issue.6475, pp.64-71, 1994.
DOI : 10.1038/369064a0

S. Poort, F. Rosendaal, P. Reitsma, and R. Bertina, A common genetic variation in the 3'untranslated region of prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, vol.88, pp.3698-703, 1996.

P. Mannucci and M. Franchini, Classic thrombophilic gene variants, Thrombosis and Haemostasis, vol.114, issue.5, pp.885-894, 2015.
DOI : 10.1160/TH15-02-0141

J. Levine, D. Branch, and J. Rauch, The Antiphospholipid Syndrome, New England Journal of Medicine, vol.346, issue.10, pp.752-63, 2002.
DOI : 10.1056/NEJMra002974

E. Harris, A. Gharavi, M. Boey, B. Patel, C. Mackworth-young et al., ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS, The Lancet, vol.322, issue.8361, pp.1211-1215, 1983.
DOI : 10.1016/S0140-6736(83)91267-9

J. Hunt, H. Mcneil, G. Morgan, R. Crameri, and S. Krilis, A Phospholipid-?2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection, Lupus, vol.884, issue.1, pp.75-81, 1992.
DOI : 10.1016/0304-4165(86)90237-0

S. Miyakis, M. Lockshin, T. Atsumi, D. Branch, R. Brey et al., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), Journal of Thrombosis and Haemostasis, vol.75, issue.2, pp.295-306, 2006.
DOI : 10.1093/ajcp/103.1.103

R. Cervera, J. Piette, J. Font, M. Khamashta, Y. Shoenfeld et al., Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis & Rheumatism, vol.15, issue.suppl 7, pp.1019-1046, 2002.
DOI : 10.1006/jaut.2000.0423

M. Petri, Epidemiology of the Antiphospholipid Antibody Syndrome, Journal of Autoimmunity, vol.15, issue.2, pp.145-51, 2000.
DOI : 10.1006/jaut.2000.0409

A. Sestak, O. Neil, K. Galli, M. Luciani, D. Bertolini et al., Familial lupus and antiphospholipid syndrome Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature, Lupus. Blood, vol.16101, pp.556-563, 2003.

R. Nayfe, I. Uthman, J. Aoun, E. Saad-aldin, M. Merashli et al., Seronegative antiphospholipid syndrome, Rheumatology, vol.52, issue.8, pp.1358-67, 2013.
DOI : 10.1093/rheumatology/ket126

S. Negrini, F. Pappalardo, G. Murdaca, F. Indiveri, and F. Puppo, The antiphospholipid syndrome: from pathophysiology to treatment, Clinical and Experimental Medicine, vol.2, issue.9, 2016.
DOI : 10.1111/j.1538-7836.2004.00904.x

B. Giannakopoulos and S. Krilis, The Pathogenesis of the Antiphospholipid Syndrome, New England Journal of Medicine, vol.368, issue.11, pp.1033-1077, 2013.
DOI : 10.1056/NEJMra1112830

J. Gris, I. Quéré, M. Sanmarco, B. Boutiere, E. Mercier et al., Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study-NOHA, Thromb Haemost, vol.84, pp.228-264, 2000.

M. Charakida, C. Besler, J. Batuca, S. Sangle, S. Marques et al., Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome, JAMA, vol.302, issue.11, pp.1210-1217, 2009.
DOI : 10.1001/jama.2009.1346

O. Amengual, T. Atsumi, M. Khamashta, and G. Hughes, The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome, Thromb Haemost, vol.79, pp.276-81, 1998.

J. Kassis, C. Neville, J. Rauch, L. Busque, E. Chang et al., Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis, Thrombosis and Haemostasis, vol.92, pp.1312-1321, 2004.
DOI : 10.1160/TH04-03-0138

I. Cavazzana, N. Manuela, C. Irene, A. Barbara, S. Sara et al., Complement activation in anti-phospholipid syndrome: A clue for an inflammatory process?, Journal of Autoimmunity, vol.28, issue.2-3, pp.160-164, 2007.
DOI : 10.1016/j.jaut.2007.02.013

Q. Reynaud, J. Lega, P. Mismetti, C. Chapelle, D. Wahl et al., Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis, Autoimmunity Reviews, vol.13, issue.6, pp.595-608, 2014.
DOI : 10.1016/j.autrev.2013.11.004

J. Rosencher, T. Mirault, I. Martinez, T. Zhu, E. Messas et al., Facteurs de risque de r?cidive de la maladie thromboembolique veineuse, Revue des Maladies Respiratoires, vol.28, issue.4, pp.453-462, 2011.
DOI : 10.1016/j.rmr.2010.10.036

S. Schulman, E. Svenungsson, and S. Granqvist, Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy, The American Journal of Medicine, vol.104, issue.4, pp.332-340, 1998.
DOI : 10.1016/S0002-9343(98)00060-6

J. De-godoy, M. De-godoy, and D. Braile, Recurrent Thrombosis in Patients with Deep Vein Thrombosis and/or Venous Thromboembolism Associated with Anticardiolipin Antibodies, Angiology, vol.57, issue.1, pp.79-83, 2006.
DOI : 10.1177/000331970605700111

V. Pengo, A. Ruffatti, C. Legnani, S. Testa, T. Fierro et al., Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study, Blood, vol.118, issue.17, pp.4714-4722, 2011.
DOI : 10.1182/blood-2011-03-340232

R. Asherson and R. Cervera, Review: antiphospholipid antibodies and the lung, J Rheumatol, vol.22, pp.62-68, 1995.

R. Cervera, R. Serrano, G. Pons-estel, L. Ceberio-hualde, Y. Shoenfeld et al., Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients, Annals of the Rheumatic Diseases, vol.82, issue.(Suppl 7), pp.1011-1019, 2015.
DOI : 10.1097/01.md.0000091181.93122.55

L. Stojanovich, Pulmonary manifestations in antiphospholipid syndrome, Autoimmunity Reviews, vol.5, issue.5, pp.344-352, 2006.
DOI : 10.1016/j.autrev.2006.02.002

J. Alijotas-reig, R. Ferrer-oliveras, E. Esteve-valverde, A. Ruffatti, A. Tincani et al., Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208?cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort, American Journal of Reproductive Immunology, vol.112, issue.abst suppl, pp.164-71, 2016.
DOI : 10.1160/TH14-03-0191

J. Shamonki, J. Salmon, E. Hyjek, and R. Baergen, Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies, American Journal of Obstetrics and Gynecology, vol.196, issue.2, p.167, 2007.
DOI : 10.1016/j.ajog.2006.10.879

M. Lockshin, M. Kim, C. Laskin, M. Guerra, D. Branch et al., Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies, Arthritis & Rheumatism, vol.114, issue.Suppl, pp.2311-2318, 2012.
DOI : 10.1016/j.thromres.2004.08.006

R. Silver, C. Parker, U. Reddy, R. Goldenberg, D. Coustan et al., Antiphospholipid Antibodies in Stillbirth, Obstetrics & Gynecology, vol.122, issue.3, pp.641-57, 2013.
DOI : 10.1097/AOG.0b013e3182a1060e

T. Sugi, H. Matsubayashi, A. Inomo, L. Dan, and T. Makino, Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss*, Journal of Obstetrics and Gynaecology Research, vol.267, issue.2, pp.326-358, 2004.
DOI : 10.1046/j.1538-7836.2003.00022.x

R. Asherson, R. Cervera, D. Shepshelovich, and Y. Shoenfeld, Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?, J Rheumatol, vol.33, pp.1038-1082, 2006.

S. Wu, Z. Xu, and H. Liang, Sneddon?s syndrome: a comprehensive review of the literature, Orphanet Journal of Rare Diseases, vol.30, issue.1, p.215, 2014.
DOI : 10.1007/s00296-009-1093-2

A. Nayer and L. Ortega, Catastrophic antiphospholipid syndrome: a clinical review, J Nephropathol, vol.3, pp.9-17, 2014.

G. Espinosa, S. Bucciarelli, R. Cervera, J. Gómez-puerta, and J. Font, Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome, Autoimmunity Reviews, vol.6, issue.2, pp.68-71, 2006.
DOI : 10.1016/j.autrev.2006.06.006

W. Wilson, A. Gharavi, T. Koike, M. Lockshin, D. Branch et al., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop, Arthritis & Rheumatism, vol.7, issue.7, pp.1309-1320, 1999.
DOI : 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F

A. Ruffatti, E. Salvan, D. Ross, T. Gerosa, M. Andreoli et al., Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity, Thrombosis and Haemostasis, vol.112, issue.4, pp.727-762, 2014.
DOI : 10.1160/TH14-03-0191

R. Asherson, R. Cervera, P. De-groot, D. Erkan, M. Boffa et al., Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines, Lupus, vol.42, issue.7, pp.530-534, 2003.
DOI : 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F

G. Moore, Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants, Seminars in Thrombosis and Hemostasis, vol.40, issue.02, pp.163-71, 2014.
DOI : 10.1055/s-0033-1364185

M. Alhenc-gelas, M. Aillaud, B. Delahousse, G. Freyburger, L. Querrec et al., La recherche des facteurs biologiques de risque établis de maladie thromboembolique veineuse: état des connaissances et conséquences pour la pratique en biologie clinique, Sang Thromb Vaiss, vol.21, pp.12-39, 2009.
DOI : 10.1016/j.jmv.2008.12.102

H. Autorité and D. Santé, Recherche complémentaire et identification d'un anticoagulant lupique. Saint-Denis La Plaine: HAS, 2006.

M. Boffa, C. Boinot, D. Carolis, S. Rovere-querini, P. Aurousseau et al., Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort, Thrombosis and Haemostasis, vol.102, pp.25-28, 2009.
DOI : 10.1160/TH09-01-0043

D. Erkan, M. Harrison, R. Levy, M. Peterson, and M. Petri, Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody?positive individuals, Arthritis & Rheumatism, vol.113, issue.7, pp.2382-91, 2007.
DOI : 10.1136/bmj.309.6963.1215

G. Ruiz-irastorza, M. Cuadrado, I. Ruiz-arruza, R. Brey, M. Crowther et al., Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies, Lupus, vol.7, issue.2, p.206, 2011.
DOI : 10.1111/j.1538-7836.2009.03588.x

G. Finazzi, R. Marchioli, V. Brancaccio, P. Schinco, F. Wisloff et al., A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)1, Journal of Thrombosis and Haemostasis, vol.68, issue.5, pp.848-53, 2005.
DOI : 10.1001/jama.291.5.576

M. Crowther, J. Ginsberg, J. Julian, J. Denburg, J. Hirsh et al., A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome, New England Journal of Medicine, vol.349, issue.12, pp.1133-1141, 2003.
DOI : 10.1056/NEJMoa035241

S. Sciascia, G. Sanna, V. Murru, D. Roccatello, M. Khamashta et al., GAPSS: the Global Anti-Phospholipid Syndrome Score, Rheumatology, vol.52, issue.8, pp.1397-403, 2013.
DOI : 10.1093/rheumatology/kes388

URL : http://doi.org/10.1093/rheumatology/kes388

D. Kyburz, F. Brentano, and S. Gay, Mode of action of hydroxychloroquine in RA?evidence of an inhibitory effect on toll-like receptor signaling, Nature Clinical Practice Rheumatology, vol.52, issue.9, pp.458-467, 2006.
DOI : 10.4049/jimmunol.168.10.5303

A. Schmidt-tanguy, J. Voswinkel, D. Henrion, J. Subra, L. Loufrani et al., Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients, J Thromb Haemost, vol.11, pp.1927-1936, 2013.

S. Cowchock and D. Balaban, Efficacy of prednisone treatment to prevent recurrent fetal death, American Journal of Obstetrics and Gynecology, vol.162, issue.4, pp.1128-1137, 1990.
DOI : 10.1016/0002-9378(90)91341-9

M. Lockshin, M. Druzin, and T. Qamar, Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody, American Journal of Obstetrics and Gynecology, vol.160, issue.2, pp.439-443, 1989.
DOI : 10.1016/0002-9378(89)90468-7

I. Hasegawa, K. Takakuwa, S. Goto, K. Yamada, N. Sekizuka et al., Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody, Human Reproduction, vol.7, issue.2, pp.203-207, 1992.
DOI : 10.1093/oxfordjournals.humrep.a137617

F. Cowchock, E. Reece, D. Balaban, D. Branch, and L. Plouffe, Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment, American Journal of Obstetrics and Gynecology, vol.166, issue.5, pp.1318-1341, 1992.
DOI : 10.1016/0002-9378(92)91596-3

A. Mekinian, M. Lazzaroni, A. Kuzenko, J. Alijotas-reig, A. Ruffatti et al., The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study, Autoimmunity Reviews, vol.14, issue.6, pp.498-502, 2015.
DOI : 10.1016/j.autrev.2015.01.012

S. Bucciarelli, G. Espinosa, R. Cervera, D. Erkan, J. Gómez-puerta et al., Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients, Arthritis & Rheumatism, vol.11, issue.8, pp.2568-76, 2006.
DOI : 10.1002/art.22018

I. Uthman, A. Shamseddine, and A. Taher, The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome, Transfusion and Apheresis Science, vol.33, issue.1, pp.11-18, 2005.
DOI : 10.1016/j.transci.2004.10.025

V. Ulrich, E. Konaniah, W. Lee, S. Khadka, Y. Shen et al., Antiphospholipid Antibodies Attenuate Endothelial Repair and Promote Neointima Formation in Mice, Journal of the American Heart Association, vol.3, issue.5, p.1369, 2014.
DOI : 10.1161/JAHA.114.001369

C. Belizna, A. Lartigue, J. Favre, D. Gilbert, F. Tron et al., Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?, Lupus, vol.41, issue.3, pp.185-94, 2008.
DOI : 10.1093/rheumatology/41.suppl_2.17

Y. Benhamou, S. Miranda, G. Armengol, N. Harouki, L. Drouot et al., Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress, Vascular Pharmacology, vol.71, pp.93-101, 2015.
DOI : 10.1016/j.vph.2015.03.014

M. Rg and . Biggs-r, A thrombin generation test; the application in haemophilia and thrombocytopenia, J Clin Pathol, vol.6, pp.3-8, 1953.

H. Hemker, A. Dieri, R. , D. Smedt, E. Béguin et al., Thrombin generation, a function test of the haemostatic-thrombotic system, Thromb Haemost, vol.96, pp.553-61, 2006.

Y. Dargaud, R. Luddington, E. Gray, T. Lecompte, T. Siegemund et al., Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study, Thrombosis Research, vol.125, issue.4, pp.353-359, 2010.
DOI : 10.1016/j.thromres.2009.11.012

L. Filippin, F. Debaugnies, F. Noubouossie, P. Lê, A. Ferster et al., Test de génération de thrombine: importance d'établir les valeurs de référence en fonction de l'âge et des concentrations en facteur tissulaire avant l'implémentation au laboratoire, pp.69-73

G. Gerotziafas, F. Depasse, J. Busson, L. Leflem, I. Elalamy et al., Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram- Thrombinoscope assay, Thrombosis Journal, vol.3, issue.1, p.16, 2005.
DOI : 10.1186/1477-9560-3-16

G. Hron, M. Kollars, B. Binder, S. Eichinger, and P. Kyrle, Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation, JAMA, vol.296, issue.4, pp.397-402, 2006.
DOI : 10.1001/jama.296.4.397

A. Tripodi, C. Legnani, V. Chantarangkul, B. Cosmi, G. Palareti et al., High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism, Journal of Thrombosis and Haemostasis, vol.2, issue.8, pp.1327-1360, 2008.
DOI : 10.1161/01.CIR.92.10.2800

M. Besser, C. Baglin, R. Luddington, . Van-hylckama, A. Vlieg et al., High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study, Journal of Thrombosis and Haemostasis, vol.138, issue.10, pp.1720-1725, 2008.
DOI : 10.7326/0003-4819-125-1-199607010-00001

. Van-hylckama, A. Vlieg, and T. Baglin, The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: reply, Journal of Thrombosis and Haemostasis, vol.13, issue.12, pp.2286-2293, 2015.
DOI : 10.1111/jth.13170

. Van-hylckama, A. Vlieg, S. Christiansen, R. Luddington, S. Cannegieter et al., Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence, British Journal of Haematology, vol.1, issue.6, pp.769-74, 2007.
DOI : 10.1111/j.1365-2141.2007.06738.x

N. Hézard, L. Bouaziz-borgi, M. Remy, and P. Nguyen, Utility of Thrombin-Generation Assay in the Screening of Factor V G1691A (Leiden) and Prothrombin G20210A Mutations and Protein S Deficiency, Clinical Chemistry, vol.52, issue.4, pp.665-70, 2006.
DOI : 10.1373/clinchem.2005.063339

M. Alhenc-gelas, M. Canonico, P. Morange, J. Emmerich, and . Group, Protein S inherited qualitative deficiency: novel mutations and phenotypic influence, Journal of Thrombosis and Haemostasis, vol.8, issue.Suppl 1, pp.2718-2744, 2010.
DOI : 10.1111/j.1538-7836.2010.04073.x

URL : https://hal.archives-ouvertes.fr/inserm-01142383

V. Regnault, S. Béguin, D. Wahl, E. De-maistre, C. Hemker et al., Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants, Thromb Haemost, vol.89, pp.208-220, 2003.

S. Tchaikovski, B. Van-vlijmen, J. Rosing, and G. Tans, Development of a calibrated automated thrombography based thrombin generation test in mouse plasma, Journal of Thrombosis and Haemostasis, vol.70, issue.10, pp.2079-86, 2007.
DOI : 10.1046/j.1365-2141.2003.04443.x

M. Ninivaggi, H. Kelchtermans, M. Kuijpers, B. Hemmeryckx, J. Heemskerk et al., Whole blood thrombin generation in Bmal1-deficient mice, Thrombosis and Haemostasis, vol.112, issue.2, pp.271-276, 2014.
DOI : 10.1160/TH13-11-0910

Y. Dargaud, H. Spronk, P. Leenders, and H. Hemker, Monitoring platelet dependent thrombin generation in mice, Thrombosis Research, vol.126, issue.5, pp.436-477, 2010.
DOI : 10.1016/j.thromres.2010.08.007

D. Tsakiris, L. Scudder, H. Dilke, K. Hynes, R. Coller et al., Hemostasis in the Mouse (Mus Musculus) : A Review, Thromb Hemost, vol.81, pp.177-88, 1999.

J. Perreira, G. Alfaro, M. Goycoolea, T. Quiroga, M. Ocqueteau et al., Circulating platelet-derivated microparticles in systemic lupus erythematosus. Association with thrombin generation and procoagulant state, Thromb Haemost, vol.95, pp.94-103, 2006.

R. Chaireti, C. Jennersjo, and T. Lindahl, Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInk?ping Study on Thrombosis (LIST) ? A 7-year follow-up, Thrombosis Research, vol.131, issue.2, pp.135-144, 2013.
DOI : 10.1016/j.thromres.2012.11.015